BTIG analyst Gregory Lewis maintains American Bitcoin (NASDAQ:ABTC) with a Buy and lowers the price target from $15 to $12.
OPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and p...
Cytokinetics reported third quarter 2026 revenue of US$47.56 million versus US$1.94 million a year earlier, with the quarterly net loss narrowing to U...
Novo Nordisk shows commercial recovery with accelerating patient additions in obesity and diabetes. Read why NVO stock is a hold.
MetroCity Bankshares (MCBS) moved into focus after its third quarter update, as the regional lender reported net interest income of $43.56 million and...
DigitalOcean Holdings reported Q3 2026 revenue of US$321.19 million with continued profitability on a nine month basis and raised full year 2026 and 2...
Roivant Sciences has seen its stock deliver significant gains in recent years, which naturally raises the question of whether the current share price ...
L3Harris buy case: record backlog, rising revenue, and defense contracts support growth with 17% upside potential.
BTIG analyst Clark Lampen maintains AppLovin (NASDAQ:APP) with a Buy and raises the price target from $396 to $450.
Nu Holdings remains fundamentally strong despite recent market volatility, with the stock trading around $12. See why I rate NU stock a Buy now.
Arm CEO Rene Haas acknowledged AMD’s long lead in data center chips but said Arm is serious about competing with its first chip.
Warren and Cuban question whether the CVS Health split will help patients after Joyner’s CNBC comments.
RDW missed revenue estimates, while VOYG beat sales forecasts and added NASA work.
Despite a robust Q3 earnings season, tech stocks have been aggressively beaten down. As November rolls in, the probability of the market switching gea...
American Bitcoin Corp. co-founder Eric Trump said on Wednesday, November 4, that Bitcoin’s latest spike reflected the new reality of a "split gove...
Coinbase has underperformed the broader market. However, Wall Street sentiment remains cautiously optimistic, with analysts leaning toward a recovery.
TD Cowen analyst Andrew M. Charles maintains Dutch Bros (NYSE:BROS) with a Buy and lowers the price target from $55 to $50.
2026-11-05. The following slide deck was published by Sunrun Inc.
2026-11-05. The following slide deck was published by The Andersons, Inc.
ACM Research (NASDAQ:ACMR) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.48 by 14.58 percent. This is...
Loading...